A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results

被引：0

作者：

Lampertico, Pietro ^{[1
]}

Buti, Maria ^{[2
]}

Ramji, Alnoor ^{[3
]}

Fung, Scott ^{[4
]}

Ahn, Sang Hoon ^{[5
]}

Chuang, Wan-Long ^{[6
]}

Yoon, Seung Kew ^{[7
]}

Kao, Jia-Horng ^{[8
]}

Chen, Chi-Yi ^{[9
]}

Tam, Edward ^{[10
]}

Khalili, Mandana ^{[11
]}

Bae, Ho ^{[12
]}

Ma, Xiaoli ^{[13
]}

Tak, Won Young ^{[14
]}

Flaherty, John F. ^{[15
]}

Gaggar, Anuj ^{[15
]}

Suri, Vithika ^{[15
]}

Tan, Susanna ^{[15
]}

Liu, Yang ^{[15
]}

Wu, George ^{[15
]}

Subramanian, Mani ^{[15
]}

Hann, Hie-Won ^{[16
]}

Agarwal, Kosh ^{[17
]}

Lim, Young-Suk ^{[18
,19
]}

Chan, Henry ^{[19
,20
]}

机构：

[1] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[2] Hosp Gen Univ Valle Hebron & Ciberehd, Barcelona, Spain

[3] Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada

[4] Toronto Gen Hosp, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada

[5] Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea

[6] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[7] Catholic Univ Korea, Dept Internal Med, Seoul, South Korea

[8] Natl Taiwan Univ Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan

[9] Chia Yi Christian Hosp, Chiayi, Taiwan

[10] LAIR Ctr, Vancouver, BC, Canada

[11] Univ Calif San Francisco, San Francisco, CA 94143 USA

[12] St Vincents Med Ctr, Los Angeles, CA USA

[13] Drexel Univ, Coll Med, Philadelphia, PA USA

[14] Kyungpook Natl Univ, Coll Med, Daegu, South Korea

[15] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[16] Thomas Jefferson Univ Hosp, Div Gastroenterol & Hepatol, Philadelphia, PA USA

[17] Kings Coll Hosp London, Inst Liver Studies, London, England

[18] Univ Ulsan, Ctr Liver, Asan Med Ctr, Dept Gastroenterol,Coll Med, Ulsan, South Korea

[19] Chinese Univ Hong Kong, Dept Med & Therapeut, Inst Digest Dis, Hong Kong, Peoples R China

[20] Chinese Univ Hong Kong, Dept Med & Therapeut, State Key Lab Digest Dis, Hong Kong, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

AS091

引用

页码：S67 / S68

页数：2

共 50 条

[41] CORRELATIONS BETWEEN NON-INVASIVE BIOMARKERS AND FIBROSIS SCORES IN CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) AND TENOFOVIR ALAFENAMIDE (TAF) IN PHASE 3 CLINICAL TRIALS
Ferret, Maria Asuncion Buti
Gane, Edward J.
Marcellin, Patrick
Jacobson, Ira M.
Janssen, Harry L. A.
Agarwal, Kosh
Fung, Scott K.
Chuang, Wan-Long
Pan, Calvin
Flaherty, John F.
Wang, Hongyuan
Tan, Susanna
Suri, Vithika
Gaggar, Anuj
Limw, Young-Suk
Chan, Henry Lik Yuen
HEPATOLOGY, 2020, 72 : 479A - 480A
[42] Safety and Tolerability of 96 Weeks of Tenofovir Disoproxil Fumarate (TDF) Treatment in HBeAg Negative and Positive Patients Infected with Chronic Hepatitis B (CHB)
Jacobson, Ira M.
Marcellin, Patrick
Heathcote, Jenny
Mathurin, Philippe
Gane, Ed J.
Buggisch, Peter
Husa, Petr
Krastev, Zahary
Sorbel, Jeff
Anderson, Jane
Mondou, Elsa
Rousseau, Franck
GASTROENTEROLOGY, 2009, 136 (05) : A867 - A867
[43] Safety and efficacy of switching to besifovir dipivoxil maleate in virologically-suppressed chronic hepatitis B patients with tenofovir disoproxil fumarate: 24-week interim analysis
Yim, Hyung Joon
Kim, Ji Hoon
Seo, Yeon Seok
Kim, Won
Jang, Jae Young
Lee, Sae Hwan
Kim, Yun Soo
Kim, Chang Wook
Kim, Hyoung Su
Shim, Jae-Jun
Cho, Eun Young
Kim, In Hee
Lee, Byung Seok
Lee, Jeong-Hoon
Kim, Byung Seok
Jang, Jeong Won
Lee, Hyun Woong
Kwon, Jung Hyun
Kim, Moon Young
Song, Do Seon
Yoon, Eileen
Park, Jung Gil
JOURNAL OF HEPATOLOGY, 2021, 75 : S743 - S744
[44] IMPACT OF LONG- TERM TREATMENT WITH CONTINUOUS TENOFOVIR ALAFENAMIDE ( TAF) OR AFTER SWITCH FROM TENOFOVIR DISOPROXIL FUMARATE ( TDF) ON HEPATOCELLULAR CARCINOMA ( HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B ( CHB)
Lim, Young-Suk
Wong, Grace Lai-Hung C.
Ahn, Sang Hoon
Seto, Wai-Kay
Agarwal, Kosh
Janssen, Harry L. A.
Pan, Calvin Q.
Chuang, Wan Long
Fung, Scott K.
Shalimar
Brunetto, Maurizia R.
Hui, Aric Josun
Chang, Ting-Tsung
Lim, Seng Gee
Abramov, Frida
Flaherty, John F.
Wang, Hongyuan
Yee, Leland J.
Kao, Jia-Horng
Marcellin, Patrick
Gane, Edward J.
Buti, Maria
HEPATOLOGY, 2023, 78 : S523 - S526
[45] Safety and efficacy at 1 year after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic HBV patients with risk factors for TDF use
Janssen, H.
Gane, E.
Seto, W-K
Caruntu, F. A.
Kim, H. J.
Abdurakhmanov, D.
Nishiguchi, S.
Horban, A.
Bae, H.
Mo, S.
Suri, V.
Gaggar, A.
Flaherty, J.
Kao, J-H
Brunetto, M.
Ferret, M. B.
JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 27 - 27
[46] Safety and Efficacy at 1 Year after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use
Gane, Edward
Seto, Wai Kay
Janssen, Harry L. A.
Caruntu, Florin A.
Kim, Hyung Joon
Abdurakhmanov, Dzhamal
Nishiguchi, Shuhei
Horban, Andrzej
Bae, Ho
Flaherty, John F.
Gaggar, Anuj
Suri, Vithika
Oberle, Corinna
Mo, Shuyuan
Subramanian, G. Mani
Kao, Jia-Horng
Brunetto, Maurizia
Buti, Maria
SWISS MEDICAL WEEKLY, 2018, 148 : 26S - 26S
[47] Improved Bone and Renal Safety at 1 Year after Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Results from 2 Phase 3 Studies in HBeAg-positive and HBeAg-negative Patients with Chronic Hepatitis B (CHB)
Pan, Calvin Q.
Brunetto, Maurizia R.
Hui, Aric Josun
Mehta, Rajiv
Flaherty, John F.
Suri, Vithika
Wu, George
Gaggar, Anuj
Subramanian, Mani
Nishiguchi, Shuhei
Kim, Hyung J.
Gane, Edward J.
Chuang, Wan-Long
HEPATOLOGY, 2017, 66 : 482A - 482A
[48] FACTORS ASSOCIATED WITH A LACK OF VIRAL SUPPRESSION IN CHRONIC HBV ( CHB) PATIENTS AFTER 8 YEARS OF TREATMENT WITH TENOFOVIR ALAFENAMIDE ( TAF) OR TENOFOVIR DISOPROXIL FUMARATE ( TDF) FOLLOWED BY TAF TREATMENT
Gane, Edward J.
Buti, Maria
Fung, Scott K.
Chan, Henry Lik Yuen
Izumi, Namiki
Chuang, Wan Long
Ahn, Sang Hoon
Mehta, Rajiv M.
Gurel, Selim
Abramov, Frida
Yee, Leland J.
Wang, Hongyuan
Mateo, Roberto
Flaherty, John F.
Ma, Xiaoli
Pan, Calvin Q.
Lim, Young-Suk
Marcellin, Patrick
HEPATOLOGY, 2023, 78 : S519 - S520
[49] IMPROVED BONE AND RENAL SAFETY AT 1 YEAR AFTER SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF): RESULTS FROM 2 PHASE 3 STUDIES IN HBEAG-POSITIVE AND HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Chan, Henry Lek-Yuen
Pan, Calvin
Brunetto, Maurizia
Hui, Aric Josun
Mehta, Rajiv
Flaherty, John F.
Suri, Vithika
Wu, George
Gaggar, Anuj
Subramanian, G. Mani
Nishiguchi, Shuhei
Kim, Hyung Joon
Gane, Edward
Chuang, Wan Long
GUT, 2018, 67 : A97 - A98
[50] Switching from tenofovir disoproxil fumarate and/or other oral antivirals to tenofovir alafenamide in virally suppressed CHB patients with moderate or severe renal impairment or ESRD on HD: final week 96 efficacy and safety results from a phase 2 study
Janssen, Harry L. A.
Lampertico, Pietro
Chen, Chien-Hung
Heo, Jeong
Fournier, Claire
Ahn, Sang Hoon
Tsang, Tak Yin Owen
Coffin, Carla S.
Huang, Yi-Hsiang
Reggiani, Giulio Marchesini
Hui, Aric Josun
Elkhashab, Magdy
Chen, Chi-Yi
Jafri, Syed-Mohammed
Tan, Susanna
Zhao, Yang
Suri, Vithika
Flaherty, John F.
Gaggar, Anuj
Brainard, Diana
Chuang, Wan-Long
Agarwal, Kosh
Gane, Edward
Lim, Young-Suk
JOURNAL OF HEPATOLOGY, 2021, 75 : S756 - S757

← 1 2 3 4 5 →